1. Home
  2. TTNP

TTNP

Titan Pharmaceuticals Inc.

Logo Titan Pharmaceuticals Inc.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.

Founded: N/A Country:
United States
United States
Employees: N/A City: SAN FRANCISCO
Market Cap: 5.8M IPO Year: 1996
Target Price: N/A AVG Volume (30 days): 11.6K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -7.41 EPS Growth: N/A
52 Week Low/High: $5.00 - $16.60 Next Earning Date: 05-13-2024
Revenue: $184,000 Revenue Growth: -66.97%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: